CS Paper Radar

Interpretable Multi-Instance Learning Enables Early Prediction of Key Molecular Alterations from Routine Flow Cytometry in Acute Myeloid Leukemia

Jonathan Legrand, Aguirre Mimoun, Baudouin Denis de Senneville, Audrey Bidet, Pierre-Yves Dumas, Christèle Etchegaray

cs.LG ·submitted 2026-09-16 15:30 UTC · v1

Abstract

Background: Molecular testing for NPM1 and FLT3-ITD mutations guides critical early treatment decisions in acute myeloid leukemia (AML), but results can take weeks, long after these decisions must be made. Flow cytometry, already performed within hours of admission as part of routine care, may carry enough signal to predict these mutations directly, without added cost or delay. Methods: We developed an interpretable multi-instance learning classifier based on a decision tree, in which each patient sample is modeled as a collection of individual cells and mutation status is inferred from cell-level predictions. The model was benchmarked against a random forest trained on clinical variables and a deep convolutional neural network adapted for multitube flow cytometry data. Performance was assessed by cross-validation on a discovery cohort of 197 patients and tested on an independent cohort of 161 patients, using the area under the receiver operating characteristic curve (AUROC) and positive predictive value. Results: In cross-validation on the discovery cohort, the MIL model achieved mean AUROCs of 0.96 (SD=0.05) for NPM1 and 0.86 (SD=0.10) for FLT3-ITD, outperforming the clinical baseline and matching deep learning approaches. The model then successfully generalized to the independent test cohort of 161 patients, reaching AUROCs of 0.90 (NPM1) and 0.82 (FLT3-ITD), with positive predictive values of 0.87 and 0.68, respectively. Cell-level interpretation recovered established immunophenotypic signatures (CD33${}^{+}$ /CD34___ for NPM1-mutated cases, CD33${}^{+}$ /low side-scatter for FLT3-ITD), directly linking model predictions to known biology. Conclusions: These results show that an interpretable model applied to data already collected in routine care can predict AML molecular status within hours, offering a practical route to earlier, biology-informed treatment decisions.

Closest papers

Nearest neighbours by meaning across the whole index.

Retrieval-Augmented Vision Foundation Models for Robust Leukemia Cell Classification across Multiple Microscopy Datasets

eess.IV cs.CVcs.LG ·2026-08-11 ·Carlos Zamora, Hiram Zuniga, Ulises Orozco-Rosas, Kenia Picos
published similarity 0.65
Abstract · Accepted at SPIE Optics + Photonics 2026 for oral presentation. 23 pages, 12 figures, 9 tables

Leukemia cell image classification is challenged by real-world domain shifts from acquisition, staining, illumination, and site protocols, causing single-dataset models to generalize poorly in real clinical scenarios. This work presents a robust framework for leukemia classification across multiple heterogeneous datasets using a two-stage pipeline with a pretrained vision foundation model. Stage 1 performs binary classification (leukemia vs. non-leukemia) and is trained using 122,167 single-cell images. Stage 2 is conditionally applied to Stage 1 positives to perform subtype classification into Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML), trained using 69,400 single-cell images. Labels are harmonized across five heterogeneous datasets to enable cross-dataset training, and performance is evaluated on a held-out dataset protocol to assess domain-shift generalization. Within this pipeline, three encoders are benchmarked (DinoBloom, pretrained on single-cell images; BiomedCLIP, pretrained on biomedical data; and CLIP as a general-purpose model) under linear probing, Low-Rank Adaptation (LoRA), and a Retrieval-Augmented Classification (RAC) module that retrieves the top-k most similar cell images to provide cytomorphological grounding. The objective is to quantify how much domain-specific pretraining contributes to performance under domain shift, and whether cost-effective adaptation and retrieval can be a viable alternative to expensive domain-specialized pretraining. The held-out protocol additionally serves as a diagnostic tool, revealing when classification performance is attributable to dataset-specific artifacts rather than to cytomorphological features.

0.28

Morphology-aware deep learning predicts colorectal cancer survival from whole-slide images

cs.CV cs.AIcs.LG ·2026-10-13 ·Hikmat Khan, Metin N. Gurcan, Anil Parwani, Wendy L. Frankel, Wei Chen +1 more
similarity 0.60
Abstract · Supplementary material included: one figure and two tables

Background: Five-year survival prediction from hematoxylin-and-eosin whole-slide images could support risk stratification, but the task is weakly supervised, and the tissue morphologies carrying prognostic information remain incompletely characterized. Methods: We conducted a retrospective secondary analysis using TCGA-COAD/READ (n=562) for morphology-specific analysis, Alliance/ CALGB 89803 (n=424) for model development, and SurGen (n=218) for external evaluation. We propose MorphContrast, a morphology-aware contrastive multiple-instance learning framework that uses tissue labels as structural supervision for five-year survival prediction. MorphContrast combines gated-attention pooling with three auxiliary objectives: patch-level morphology labels define within-patient contrasts, outcome concordance or discordance defines cross-patient contrasts within matched morphologies, and diversity regularization discourages representational collapse. Morphology-matched patches from patients with discordant outcomes serve as hard negatives, encouraging prognostic discrimination within comparable histologic contexts. Results: Morphology-specific models show weak but distributed prognostic discrimination: adipose tissue achieves an area under the receiver operating characteristic curve (AUC) of 0.622, stroma achieves 0.604, and both perform comparably to tumor epithelium (0.601-0.605). On Alliance/CALGB 89803, the single model achieves an AUC of 0.642, while the post hoc ensemble reaches a pooled out-of-fold AUC of 0.70 and a risk-group hazard ratio of 3.79 (95% confidence interval: 2.55-5.63). On the external SurGen colon cancer cohort (n=218), the single model and ensemble achieve AUCs of 0.669 and 0.678, respectively. Conclusions: These findings support tissue morphology as structural supervision for outcome-aware representation learning in colorectal cancer prognosis.

0.14

Deep Learning for Cervical Cytology Screening: Methods, Algorithms, Challenges and Prospects

cs.CV ·2026-11-01 ·Jiang Yangbo, Zheng Nenggan
benchmark similarity 0.60
Abstract

Cervical cancer remains a leading cause of cancer death among women, with more than 90\% of deaths occurring in low- and middle-income countries, where cytology screening is constrained by a shortage of trained cytopathologists. Deep learning has made automated cytology screening increasingly feasible, but the literature is fragmented across cell, patch and whole-slide-image scales, task formulations and supervision regimes, hindering comparison and clinical translation. This Review synthesizes the deep learning literature for cervical cytology screening, organizing the field along three axes---data scale, functional task and supervision---and distinguishing two clinical roadmaps: whole-slide-image confidence aggregation and cell-level detection with Bethesda classification. We examine 16 publicly available or publicly documented cytology datasets alongside the CAISHI histopathology dataset, compare quantitative performance while exposing incomparable metrics and data leakage, and assess commercial systems, regulatory status, HPV-era screening pathways and low-resource deployment. Single-cell accuracy on Herlev and SIPaKMeD has plateaued, but this reflects benchmark saturation rather than clinical readiness; prospective and randomized evidence is emerging but remains limited. We consolidate the evidence into five challenge areas---data and benchmarks, architecture and label-efficient learning, trustworthy AI, clinical translation and health economics, and evaluation and reproducibility---and provide an evidence-to-agenda map and a deployment decision matrix. Progress now depends on multi-center benchmarks, externally validated label-efficient methods, calibrated and fair predictions, and pragmatic clinical trials rather than further gains on saturated single-cell benchmarks.

0.09

A Tumour-Aware Multimodal Framework for Explainable Prediction of IDH Mutation in Gliomas from Multi-Sequence MRI

eess.IV cs.CV ·2026-11-13 ·Tahsien Al-Quraishi, Waseem Alwan Zaboon, O. S. Albahri, Raza Nowrozy
similarity 0.60
Abstract · 45 pages, 12 figures, 4 tables. Preprint of an article submitted for consideration in International Journal of Information Technology & Deci…

Accurate prediction of isocitrate dehydrogenase (IDH) mutation status is essential for glioma diagnosis, prognosis, and treatment planning. Although recent deep learning approaches have demonstrated promising performance, many rely on whole-brain feature extraction and provide limited interpretability. This study proposes a tumour-aware multimodal framework for explainable, non-invasive prediction of IDH mutation status from multiparametric magnetic resonance imaging (MRI). The proposed framework integrates four MRI sequences (T1, T1CE, T2, and FLAIR), tumour subregion segmentation, quantitative radiomic descriptors, and clinical information within a unified deep learning architecture. An ablation study was conducted to evaluate the contribution of tumour-aware learning, radiomic features, and clinical variables. Model performance was assessed using multiple complementary evaluation metrics, including accuracy, precision, recall, F1-score, balanced accuracy, receiver operating characteristic analysis, confusion matrix evaluation, and Grad-CAM visualisation. Experimental results demonstrated that the proposed multimodal framework consistently outperformed the baseline MRI-only model, with the Clinical Fusion model achieving the strongest overall predictive performance. The integration of tumour-aware learning, radiomic descriptors, and clinical information progressively improved classification performance, while Grad-CAM visualisations indicated that the model predominantly focused on biologically relevant tumour regions. These findings suggest that tumour-aware multimodal feature integration enables accurate, interpretable, and non-invasive molecular profiling of gliomas and provides a promising foundation for future clinical decision support in precision neuro-oncology.

0.12

IFC-SSL-Bench: Benchmarking Self-Supervised Learning for Annotation-Efficient Multispectral Imaging Flow Cytometry

cs.CV ·2026-10-22 ·Angelo Jovin Yamachui Sitcheu, Roxana-Teodora Fetescu, Thomas Lautenschlager, Nils Friederich, Linus Schilpp +4 more
benchmark similarity 0.59
Abstract · 35 pages, six main figures, seven supplementary figures, five tables and four supplemntary tables

Imaging Flow Cytometry (IFC) generates large multispectral datasets, yet the need for expert annotations bottlenecks the development of supervised deep learning models. While Self-Supervised Learning (SSL) offers a solution, its application to IFC remains fragmented and lacks systematic benchmarking. To address this, we present IFC-SSL-Bench, a modular framework for evaluating SSL in IFC. We benchmark six SSL approaches across four backbones on two heterogeneous datasets. By assessing downstream classification performance across annotation regimes of the training sets (1%-100%), we quantify annotation efficiency and identify optimal configurations for high-dimensional biological imaging. SSL matches the performance of fully supervised baselines trained on 100% of annotated data while using as little as 5% of annotations for morphological classification, with advantages in low-data regimes below 5%. Across both datasets, the contrastive approach MoCo-v2 paired with ConvNeXt backbones emerged as the top-performing configuration, with ConvNeXtV1-T best for immunological synapse classification and ConvNeXtV2-T for morphological classification. We identify a clear pattern in transfer dynamics: ImageNet initialization benefits morphological classification, consistent with its visual similarity to natural images, whereas random initialization better captures the more domain-specific immunological synapse classification. SSL elevates class-specific F1-scores by over 35 percentage points for structurally complex classes at 1% of annotated data. We synthesize these insights into a unified set of guidelines for deploying self-supervised workflows in high-throughput IFC, and release the benchmark as a resource for future work.

0.27

CytoBERT: A Foundation Model for Cytometry Data

cs.LG ·2026-08-14 ·Syed Abdul Haseeb Qadri, Bjarne C. Hiller, Felix Blanke, Vanja Sophie Cangalovic, Kutalmış Coşkun +5 more
code/data similarity 0.59
Abstract

Cytometry measures the complex characteristics of single cells (e.g., counts and protein expression of immune cells) and is widely used across immunological research and clinical settings. However, cytometry data is highly heterogeneous and unstandardized due to experimental protocols and the choice of measured features. While machine learning methods hold the potential to gain deeper insights into cell biology, these challenges make them difficult to apply and transfer across studies. Recent advances in foundation models can alleviate these issues, but corresponding approaches are still scarce in this field. To address this, we provide CytoBERT, a publicly available, open-source, open-weight foundation model for single-cell cytometry data with variable marker panels. CytoBERT is pretrained in a self-supervised manner on a large-scale cytometry corpus (15 human datasets with heterogeneous marker panels and more than 50 million cells) curated through marker standardization, enabling it to learn transferable inter-marker relationships within cells. Fine-tuning CytoBERT for sample-level classification demonstrates that transfer learning across heterogeneous cytometry datasets is feasible, providing a starting point for scalable, generalizable cytometry analysis. Code is available at GitHub.

0.50

Multi-label versus multi-class classification of blood cells and their aggregates in microfluidic channels

cs.CV cs.LG ·2026-09-07 ·Igor Zingman, Shada Abuhattum, Sara Kaliman, Maximilian Schlögel, Paul Müller +6 more
similarity 0.58
Abstract · 26 pages, 5 figures

Deformability cytometry (DC) is a type of imaging flow cytometry, which uses a camera-equipped device to measure cellular stiffness in addition to other cellular properties at high throughput. Cellular properties such as area and elongation can identify cell types, but this requires prior knowledge of distinguishing properties and cannot be applied to clinically important cell aggregates. Using DC data, we evaluated conventional multi-class (MC) classification and introduced a multi-label (ML) approach for identifying blood cells and their aggregates. In particular, an ML classifier can simultaneously assign multiple cell-type labels to a single imaged event. We show that, unlike MC classification, ML classification can identify cell aggregates not represented in the training data. It also avoids the need for exhaustive, strictly defined aggregate labels, thereby simplifying and speeding up annotation. Since automated blood analyzers do not reliably analyze cell aggregates, our approach may help address this clinical gap.

0.32

Evaluating Single and Multi-Omics Based Explainable Artificial Intelligence (MOXAI) for Molecular Subclass Classification of Adult-Type Diffuse Gliomas

cs.CV cs.AI ·2026-09-26 ·Md Zahangir Alom, Quynh T. Tran, Breuer Alexandar, Brent A. Orr
similarity 0.57
Abstract · 8 pages, 6 figures

DNA methylation (DNAM) profiling has emerged as a powerful diagnostic tool for classifying brain and solid tumors. However, existing computational models typically analyze methylation and copy number variation (CNV) data separately, failing to capture the complementary information their integration could provide. Moreover, current classification models lack mechanisms for within-class risk assessment analogous to traditional tumor grading, and no established explainability method can attribute classification decisions to specific genomic loci. In this paper, we present MOXAI (Multi-Omics Based Explainable AI), a deep learning framework that integrates DNA methylation and copy number data from methylation arrays to classify molecular subtypes of adult-type diffuse gliomas, alongside single-modality variants for comparison. Using a cohort from The Cancer Genome Atlas (TCGA), we trained ResNet50, DINOv2, and Graph Attention Network (GAT) models on methylation data alone, copy number data alone, and combined multimodal data. We further developed explainable AI (XAI) methods based on class activation maps (CAMs) and gradient-weighted CAM (Grad-CAM) to identify the specific CpG sites, genes, and chromosomal regions most relevant to each classification decision. The multimodal model achieved up to 92.98% cross-validation accuracy, outperforming models trained on CNV data alone. DINOv2 showed the strongest generalization, reaching 94.25% accuracy (confidence >0.9) on independent validation sets. XAI results aligned with established molecular features of adult-type diffuse glioma subtypes, confirming the biological interpretability of the framework.

0.14